HDAC6 promotes cardiac fibrosis progression through suppressing RASSF1A expression

Cardiology (Switzerland)

Volumn 133, Issue 1, 2015, Pages 18-26

  Tao, Hui ^a   Yang, Jing Jing ^a   Hu, Wei ^a   Shi, Kai Hu ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac fibroblast cells; Cardiac fibrosis; Fibroblast proliferation; HDAC6; RASSF1A

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; HISTONE DEACETYLASE 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; TUBACIN; ACTIN; ANILIDE; COLLAGEN TYPE I, ALPHA 1 CHAIN; HDAC6 PROTEIN, RAT; HISTONE DEACETYLASE; HYDROXAMIC ACID; ISOPRENALINE; RASSF1 PROTEIN, RAT; SMOOTH MUSCLE ACTIN, RAT; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL PROLIFERATION; DISEASE COURSE; HEART FIBROBLAST; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE; CELL CULTURE; DISEASE MODEL; FIBROSIS; GENETICS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ACTINS; ANILIDES; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; FIBROSIS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; ISOPROTERENOL; MALE; MYOCARDIUM; MYOFIBROBLASTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS;

EID: 84942235091     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000438781     Document Type: Article

References (20)

1. Rosenberg MA, Maziarz M, Tan AY, Glazer NL, Zieman SJ, Kizer JR, et al: Circulating fibrosis biomarkers and risk of atrial fibrillation: the Cardiovascular Health Study (CHS). Am Heart J 2014; 167: 723-728 e2.
2. Schuetze KB, McKinsey TA, Long CS: Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs. J Mol Cell Cardiol 2014; 70: 100-107.
3. Deb A, Ubil E: Cardiac fibroblast in development and wound healing. J Mol Cell Cardiol 2014; 70: 47-55.
4. Chung CC, Hsu RC, Kao YH, Liou JP, Lu YY, Chen YJ: Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-β and angiotensin II signaling. Int J Cardiol 2014; 176: 386-393.
5. Chen Y, Yang S, Yao W, Zhu H, Xu X, Meng G, et al: Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF β-Smad signal pathway. PloS One 2014; 9:e98483.
6. Tao H, Yang JJ, Chen ZW, Xu SS, Zhou X, Zhan HY, et al: DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2. Toxicology 2014; 323: 42-50.
7. Duan C, Liu M, Zhang J, Ma R: RASSF1A: a potential novel therapeutic target against cardiac hypertrophy. Prog Biophys Mol Biol 2013; 113: 284-288.
8. Montenegro MF, Saez-Ayala M, Pinero-Madrona A, Cabezas-Herrera J, Rodriguez-Lopez JN: Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation. PloS One 2012; 7:e52231.
9. Charlet J, Szemes M, Malik KT, Brown KW: MYCN is recruited to the RASSF1A promoter but is not critical for DNA hypermethylation in neuroblastoma. Mol Carcinog 2014; 53: 413-420.
10. Qiu X, Zhang L, Lu S, Song Y, Lao Y, Hu J, et al: Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation. Oncol Rep 2014; 31: 202-208.
11. Agarwal S, Amin KS, Jagadeesh S, Baishay G, Rao PG, Barua NC, et al: Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells. Mol Cancer 2013; 12: 99.
12. Tao H, Shi KH, Yang JJ, Huang C, Zhan HY, Li J: Histone deacetylases in cardiac fibrosis: current perspectives for therapy. Cell Signal 2014; 26: 521-527.
13. Li Y, Shin D, Kwon SH: Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes. FEBS J 2013; 280: 775-793.
14. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, et al: HDAC6 is a microtubule-associated deacetylase. Nature 2002; 417: 455-458.
15. Li N, Tie XJ, Liu PJ, Zhang Y, Ren HZ, Gao X, et al: Effects of down-regulation of HDAC6 expression on proliferation, cell cycling and migration of esophageal squamous cell carcinoma cells and related molecular mechanisms. Asian Pac J Cancer Prev 2013; 14: 685-689.
16. Schulz R, Marchenko ND, Holembowski L, Fingerle-Rowson G, Pesic M, Zender L, et al: Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression. J Exp Med 2012; 209: 275-289.
17. Thum T: Noncoding RNAs and myocardial fibrosis. Nat Rev Cardiol 2014; 11: 655-663.
18. Cavalera M, Wang J, Frangogiannis NG: Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Transl Res 2014; 164: 323-335.
19. Nural-Guvener HF, Zakharova L, Nimlos J, Popovic S, Mastroeni D, Gaballa MA: HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation. Fibrogenesis Tissue Repair 2014; 7: 10.
20. Eom GH, Kook H: Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases. Pharmacol Ther 2014; 143: 168-180.